The information contained within this announcement is deemed by the Company to constitute inside
information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of
the law of England and Wales. Upon the publication of this announcement via the Regulatory
Information Service, this inside information is now considered to be in the public domain.
Press release
22 April 2022
Cellular Goods PLC
('Cellular Goods' or 'the Company')
Update on ingestibles product range
Further to the announcement of 13 April 2022, the Company has now received correspondence from Trading Standards and has agreed to suspend sales of its ingestibles range with immediate effect.
The Company is disappointed with this development and will continue to engage with the Food Standards Agency (FSA) given its ingestible products are identical to products which are entitled to remain on the market.
While the Company believes that ingestibles are an important part of the overall market, Cellular's product marketing activity to date has focused on the non-ingestible products in the Company's 'Look Better' skincare range which remains unaffected.
Anna Chokina, Chief Executive Officer of Cellular Goods, said: "We are disappointed by the FSA's stance. We will continue to engage with the regulator as we believe our products are safe, of a high quality and appropriate to be on the market. We hope the matter can be resolved soon."
For further information please contact:
| Cellular Goods | |
| Anna Chokina Chief Executive Neil Thapar Investor Relations | via Tancredi +44 207 887 7633
+44 787 645 5323 |
| Tennyson Securities | |
| Corporate Broker Peter Krens |
+44 207 186 9030 |
| Novum Securities | |
| Corporate Broker Colin Rowbury Jon Belliss |
+44 207 399 9427 |
| Tancredi Intelligent Communication | |
| Media Relations Helen Humphrey Gabriela Amaya Garcia Charlie Hobbs |
+44 744 922 6720 +44 791 503 5294 +44 789 755 7112 |
About Cellular Goods PLC:
Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
